Open-Label Extension Study to ZPE-202

NCT01961908 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: Proellex

Sponsor

Repros Therapeutics Inc.